Validation and quality control of immunophenotyping in clinical flow cytometry

Journal of Immunological Methods

Volumn 243, Issue 1-2, 2000, Pages 33-50

  Owens, Marilyn A ^a   Vall, Horacio G ^a   Hurley, Anne A ^b   Wormsley, Susan B ^c  

^a IMPATH Inc   (United States)

^b 62 Bayberry Lane ^*  (United States)

^c BD BIOSCIENCES   (United States)

Author keywords

Flow cytometry; Immunophenotyping; Leukemia diagnosis; Lymphoma diagnosis; Phenotypic analysis

Indexed keywords

FC RECEPTOR; FLUOROCHROME; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY; REAGENT;

ACCURACY; BONE MARROW; CLINICAL LABORATORY; COMPUTER PROGRAM; FLOW CYTOMETRY; FLUORESCENCE; GOOD LABORATORY PRACTICE; HUMAN; IMMUNOPHENOTYPING; INSTRUMENTATION; LEUKEMIA; LIGHT SCATTERING; LYMPHOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ASSAY; RESPONSIBILITY; REVIEW; STANDARDIZATION; VALIDATION PROCESS;

EID: 0034699436     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00226-X     Document Type: Article

References (92)

1. Allen J.R., Earp R., Farrell C.E., Gruemer H.D. Analytical bias in a quality control scheme. Clin. Chem. 15:1969;1039.
2. Almasri N., Duque R., Iturraspe J., Everett E., Braylan R. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am. J. Hematol. 40:1992;259.
3. Bagwell, C.B., Adams, E.G., 1993. Fluorescence spectral overlap compensation for any number of flow cytometric parameters. In: Landay, A., Ault, K.A., Bauer, K.D., Rabinovitch, P. (Eds.), Clinical Flow Cytometry. Ann. New York Acad. Sci. 677(94), 167-184.
4. Banks P.M., Chan J., Cleary M.L., Delsol G., De Wolf-Peeters C., Gatter K., Grogan T.M., Harris N.L., Isaacson P.G., Jaffe E.S., et al. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am. J. Surg. Pathol. 16:1992;637-640.
5. Belk W.P., Sunderman F.W. A survey on the accuracy of chemical analysis in clinical laboratories. Am. J. Clin. Pathol. 17:1947;854.
6. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., vant Veer M.B. Proposals for the immunological classification of acute leukemias: European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 9:1995;1783-1786.
7. Borowitz M., Bach B.A., Bauer K.D., Duque R.E., Horton A.F., Johnson R.L., Marti G., Muirhead K., Peiper S., Rickman W. Immunophenotyping of Leukemic Cells: Proposed Guidelines. 1993;NCCLS, Villanova, PA.
8. Borowitz M.J., Guenther K.L., Shults K.E., Stelzer G.T. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am. J. Clin. Pathol. 100:1993;534-540.
9. Borowitz M.J., Bray R., Gascoyne R., Melnick S., Parker J.W., Picker L., Stetler-Stevenson M. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry. 30:1997;236-244.
10. Brando B., Sommaruga E. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. Cytometry. 14:1993;294-306.
11. Braylan R.C., Benson N.S., Iturraspe J. Analysis of lymphomas by flow cytometry: current and emerging strategies. Ann. New York Acad. Sci. 677:1993;364-378.
12. Braylan R.C., Borowitz M.J., Davis B.H., Stelzer G.T., Stewart C.C. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Cytometry. 30:1997;213.
13. Braylan R.C., Atwater S.K., Diamond L., Hassett J.M., Johnson M., Kidd P.G., Leith C., Nguyen D. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. Cytometry. 30:1997;245-248.
14. Campana D., Pui C.H. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood. 85:1993;1416-1434.
15. Carter P.H., Resto-Ruiz S., Washington G.C., Ethridge S., Palini A., Vogt R., Waxdal M., Fleisher T., Noguchi P.D., Marti G.E. Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations. Cytometry. 13:1992;68-74.
16. Cavelli T., Denny T., Paxton H., Gelman R., Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 14:1993;702-715.
17. Cheson B., Bennett J., Grover M., Kay N., Keating M., O'Brien S., Rai K. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 87:1996;4990-4997.
18. Civin C., Loken M. Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. Murphy M. Concise Reviews in Clinical and Experimental Hematology. 1992;AlphaMed Press, Dayton, OH.
19. Davis B.H., Bigelow N.C. Clinical flow cytometric reticulocyte analysis. Pathobiology. 58:1990;99-106.
20. Davis R.E., Longacre T.A., Cornbleet P.J. Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis. Am. J. Clin. Pathol. 102:1994;202-211.
21. Davis B.H., Foucar K., Szczarkowski W., Ball E., Witzig T., Foon K.A., Wells D., Kotylo P., Johnson R., Hanson C., Bessman D. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry. 30:1997;249-263.
22. Department of Health and Human Services, 1992. Health Care Financing Administration, Public Health Service 42 CFR Part 405, Clinical Laboratory Improvement Act 1988.
23. Dorsey D.B. The evaluation of proficiency testing in the USA. Proceedings of the Second National Conference on Proficiency Testing, Bethesda, MD, Information Services :1975.
24. Federal Register, 1997. Medical devices. Classification/reclassification; restricted devices; analyte specific reagents. Health and Human Services, Federal Register 61, Docket No. 96N-0082.
25. Ford R.A., Tamayo P., Martin B., Niu K., Claypool K., Cabanillas F., Ambrus J. Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas. Blood. 86:1995;283-293.
26. Geisler C., Larsen J., Hansen N., Hansen M., Christensen B., Lund B., Nielsen H., Piesner T., Thorling K., Andersen A. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell CLL. Blood. 78:1991;1795-1802.
27. Givan A.L., Calvert J.E., Shenton B.K. The effect of improvements in cytometer sensitivity on the detection of CD5-positive B cells with dim fluorescence. Cytometry. 12:1991;360-365.
28. Grannis G.F., Gruemer H.D., Lott J.A., Edison J.A., McCabe W.C. Proficiency evaluation of clinical chemistry laboratories. Clin. Chem. 18:1972;222.
29. Hassett J., Parker J. Laboratory practices in reporting flow cytometry phenotyping results for leukemia/lymphoma specimens: results of a survey. Cytometry. 22:1995;264-281.
30. Henry R.J. Use of the control chart in clinical chemistry. Clin. Chem. 5:1959;309.
31. Henry R.J., Segalove M. The running of standards in clinical chemistry and the use of the control chart. J. Clin. Pathol. 5:1952;305.
32. Hertler A.A., Schlossman D.M., Borowitz M.J., Laurent G., Jansen F.K., Schmidt C., Frankel A.E. A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia. J. Biol. Response Modifiers. 140:1988;2322-2329.
33. Hurley A.A. Quality control in flow cytometry. Cytometry. (Suppl. 3):1988.
34. Hurley A.A. Principles of quality control. Current Protocols in Cytometry. 1997;Wiley, New York.
35. Hurley A.A. Components of quality control. Current Protocols in Cytometry. 1997;Wiley, New York.
36. Hurley A.A. Quality control in phenotypic analysis by flow cytometry. Current Protocols in Cytometry. 1997;Wiley, New York.
37. Hurley A.A., Zito D.R. Regulatory affairs. Cytometry. 34:(5):1998.
38. Hurley A.A., Zito D.R. The ISAC Cytometry CLIA Compliance Manual. 1998;International Society for Analytical Cytology/Wiley Liss.
39. Hurwitz C., Loken M., Graham M., Karp J., Borowitz M., Pullen D., Civin C. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood. 72:1988;299-307.
40. Jacobberger, X., Bauer, K., personal communication.
41. Jamieson G.P., Brocklebank A.M., Snook M.B., Sawyer W.H., Buolamwini J.K., Paterson A.R.P., Wiley J.S. Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells. Cytometry. 14:1993;32-38.
42. Kilo M., Dorfman D. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic leukemia from mantle cell lymphoma. Am. J. Clin. Pathol. 105:1996;451-457.
43. Kishimoto T., Kikutani H., von dem Borne A.E.G., Goyert S.M., Mason D.Y., Miyasaka M., Moretta L., Okumura K., Shaw S., Springer T.A., Sugamura K., Zola H. White Cell Differentiation Antigens. Leucocyte Typing. Vol. VI:1997;Garland, New York.
44. Ladenson J.H. Patients as their own controls: use of the computer to identify laboratory error. Clin. Chem. 21:1975;1648.
45. Levy S., Jennings E.R. The use of control charts in the clinical laboratory. Am. J. Clin. Pathol. 20:1950;1059.
46. Loeffler D.A., Kuruga M.A., Juneau P.L., Heppner G.H. Analysis of distribution of tumor- and preneoplasia-infiltrating lymphocytes using simultaneous Hoechst 33342 labeling and immunophenotyping. Cytometry. 13:1992;169-174.
47. Macedo A., Orfao A., Vidrailes M., Lopez-Berges M., Valverde B., Gonzalez M., Caballero M., Ramos F., Martinez M., Fernandes-Calvo J. Characterization of aberrant phenotypes in acute myeloblastic leukemia. Ann. Hematol. 70:1995;189-194.
48. McCoy J.P. Jr., Overton W.R. A survey of current practices in clinical flow cytometry. Am. J. Clin. Pathol. 106:1996;82-86.
49. McCoy J., Carey J., Kause J. Quality control in flow cytometry for diagnostic pathology. I. Cell surface immunophenotyping and general laboratory procedures. Am. J. Clin. Pathol. 1990;S27-S37.
50. Muirhead K. Quality control for clinical flow cytometry. Bauer K., Duque R., Shankey T. Clinical Flow Cytometry: Principles and Applications. 1993;177-199 Williams & Wilkins, Baltimore.
51. National Committee for Clinical Laboratory Standards, 1990. Procedures for the handling and processing of blood specimens: approved guideline. NCCLS document H18-A. NCCLS, Villanova, PA.
52. National Committee for Clinical Laboratory Standards, 1992. Clinical applications of flow cytometry. Quality assurance and immunophenotyping of peripheral blood lymphocytes. Instrumentation Section, National Committee for Clinical Laboratory Standards. Approved Guideline. NCCLS document H42-T. NCCLS, Villanova, PA.
53. National Committee for Clinical Laboratory Standards, 1997a. Clinical applications of flow cytometry. Immunophenotyping of leukemic cells. Approved Guideline. NCCLS document H43-A. NCCLS, Villanova, PA.
54. National Committee for Clinical Laboratory Standards, 1997b. Clinical applications of flow cytometry: quality assurance and immunophenotyping of peripheral blood lymphocytes. Approved Guideline. NCCLS document H42-A. NCCLS, Villanova, PA.
55. Nicholson J., Kidd P., Mandy F., Livnat D., Kagan J. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry (Commun. Clin. Cytometry). 26:1996;227-230.
56. Nicholson J., McDougal J., Hearn T., Collins C., Valleca W., Jones W., Gerger A. CDC (1994) revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. J. MMWR. 43:1994;1-21.
57. Owens M., Loken M. Flow Cytometry Principles For Clinical Laboratory Practice. Quality Assurance For Quantitative Immunophenotyping. 1995;Wiley-Liss, New York.
58. Paxton H., Kidd P., Landay A., Giorgi J., Flomenberg N., Walker E., Valentine F., Fahey J., Gelman R. Results of the Flow Cytometry ACTG Quality Control Program: analysis and findings. Clin. Immunol. Immunopathol. 52:1989;69-74.
59. Pollice A.A., McCoy J.P. Jr., Shackney S.E., Smith C.A., Agarwal J., Barholt D.R., Janocko L.E., Homicek F.J., Singh S.G., Hartsock R.J. Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry. 13:1992;432-444.
60. Press O.W., Farr A.G., Borroz K.I., Anderson S.K., Martin P.J. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res. 49:1989;4906-4912.
61. Rameshwar P., Denny T.N., Stein D., Gasc P. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-B. J. Immunol. 153:1994;2819-2830.
62. Roth G., Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies: Working Group on Flow Cytometry and Image Analysis. Leukemia. 10:1996;877-895.
63. Ryan D.H., Nuccie B.L., Abboud C.N., Winslow J.M. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 88:1991;99-1004.
64. Sasaki D., Bumas S., Engleman E. Discrimination of viable and nonviable cells using propidium iodide in two color immunofluorescence. Cytometry. 8:1987;413-420.
65. Sax S.M., Dorman L., Lebenson D.D., Moore J.J. Design and operation of an expanded system of quality control. Clin. Chem. 13:1967;825.
66. Schmid I., Krall W., Uittenbogaart C., Braun J., Giorgi J. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry. 13:1992;204-208.
67. Schwartz A., Fernandez-Repollet E., Velilla M., Ocasio B. Calibration of flow cytometers to directly measure numbers of antibody binding sites on cells. Abstracts for the XIV International Meeting of the Society for Analytical Cytology, Ashville, NC. Cytometry. (Suppl. 4):1990;463B.
68. Schwartz A., Fernandez-Repollet E., Vogt R., Gratama J. Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry (Commun. Clin. Cytometry). 26:1996;22-31.
69. Schwartz A., Fernandez Repollett E., Vogt R., Gratama J. Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry. 26:1996.
70. Segal G.H., Edinger M.G., Owens M., McNealis M., Lopez P., Perkins A., Linden M.D., Fishleder A.J., Stoler M.H., Tubbs R.R. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLA-DR on lymphoid proliferations using three-color immunocytometry. Cytometry. 12:1991;350-359.
71. Seivers E., Lange B., Buckley J., Smith F., Wells D., Daigneault-Creech C., Shults K., Bernstein I., Loken M. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J. Natl. Cancer Inst. 88:1996;1483-1488.
72. Shimenti K.J., Lacerna K., Wamble A., et al. Reticulocyte quantification by flow cytometry, image analysis, and manual counting. Cytometry. 13:1992;853-862.
73. Shuey H.E., Cebel J. Bull. US Army Med. Dept. 9:1949;799.
74. Steen H.B. Noise, sensitivity, and resolution of flow cytometers. Cytometry. 13:1991;822-830.
75. Stelzer G.T., Marti G., Hurley A., McCoy P. Jr., Lovett E.J., Schwartz A. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry. 30:1997;214-230.
76. Stewart C.C., Stewart S.J. Cell preparation for the identification of leukocytes. Darzynkiewicz A., Robinson J., Crissman H. Methods in Cell Biology. Vol. 41:1994;39-60 Academic Press, New York.
77. Stewart C.C., Stewart S.J. The use of directly and indirectly labeled monoclonal antibodies in flow cytometry. Davis W.C. Methods in Molecular Biology. Vol. 45:1995;129-147 Humana Press.
78. Stewart C.C., Stewart S.J. Titering antibodies. Robinson J.P., Darzynkiewicz Z., Dean P., Dressler L., Rabinovitch P., Stewart C., Tanke H., Wheeless I. Current Protocols in Cytometry. 1997;4.1.1-4.1.13 Wiley, New York.
79. Stewart C.C., Stewart S.J. Phenotypic analysis. Robinson J.P., Darzynkiewicz Z., Dean P., Dressler L., Rabinovitch P., Stewart C., Tanke H., Wheeless L. Current Protocols in Cytometry. 1997;6.0.1-6.2.18 Wiley, New York.
80. Stewart C.C., Stewart S.J. Four color compensation. Commun. Clin. Cytometry. 38:1999;161-175.
81. Stewart C.C., Behm F.G., Carey J.L., Cornbleet J., Duque R.E., Hudnall S.D., Hurtubise P.E., Loken M., Tubbs R.R., Wormsley S. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry. 30:1997;231-235.
82. Timm E.A., Podniesinski E., Duckett I., Cardott J., Steward C.C. Amplification and detection of a-chromosome DNA sequence by fluorescence in situ polymerase chain reaction and flow cytometry using cells in suspension. Cytometry. 22:1995;250-255.
83. Tomer A., Harker L.A. Quantitative cytometric measurement of normal human megakaryocytes. Nouv. Rev. Fr. Hematol. 31:1989;233.
84. Vogt R.F., Cross G.D., Henderson L.O., Phillips D.L. Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity of flow cytometers. Cytometry. 10:1989;294-302.
85. Vogt R.F., Cross G.D., Phillips D.L., Henderson L.O., Hannon W.H. Interlaboratory study of cellular fluorescence intensity measurements with fluorescein-labeled microbead standards. Cytometry. 12:1991;525-536.
86. Vogt R., Cross G., Phillips D., Henderson I., Hannon W. Interlaboratory study of cellular fluorescence intensity measurements with fluorescence intensity for clinical and research applications of immunophenotyping by flow cytometry. Tyler H. Reviews in Biotechnology and Bioengineering. Vol. 1:1994;Ablex, Norwood, NJ.
87. Whitehurst P., DiSilviio T.V., Boadjian G. Evaluation of discrepancies in patients results - An aspect of computer-assisted quality control. Clin. Chem. 21:1975;87.
88. Wittrup K.D., Westerman R.J., Dessai R. Fluorescence array detector for large-field quantitative fluorescence. Cytometry. 16:1994;206-213.
89. Wooten I.D.P., King E.J. Normal values for blood constituents: inter-hospital differences. Lancet. 1:1953;470.
90. Wormsley S.B., Baird S.M., Gadol N., Rai K.R., Sobol R.E. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cells subsets with chronic lymphoid leukemia immunophenotypes. Blood. 76:1990;123-130.
91. Zagursky R.J., Sharp D., Solomon K., Schwartz A. Quantitation of cellular receptors by a new immunocytochemical flow cytometry technique. BioTechniques. 18:(3):1995.
92. Zucker R.M., Elstein K.H., Gershey E.L., Massaro E.J. Increasing sensitivity of the ortho analytical cytofluorograph by modifying the fluid system. Cytometry. 11:1991;848-851.